Online citations, reference lists, and bibliographies.
← Back to Search

The Differential Diagnosis In Nonlymphoproliferative Malignant Pleural Effusion Cytopathology And Its Correlation With Patients’ Demographics

E. Rodriguez, Sayanan Chowsilpa, Z. Maleki
Published 2018 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Background: We report our experience with malignant pleural effusion (MPE) and the impact of patients’ demographics on the differential diagnosis at the primary site. Methods: After IRB approval, we searched our pathology database from January 2013 to January 2017 for patients with positive pleural effusions (PEs). Patients’ demographics and clinical histories were noted. Results: 474 patients were identified (288 females [61%] and 186 males [39%]), ranging in age from 19 to 64 years old. Ethnicity was distributed as follows: Caucasian (n = 330, 70%), African American (n = 114, 24%) and Asian (n = 30, 6%). The most common primary sites were the lung (n = 180, 37%), followed by the breast (n = 81, 17%), and the gynecologic system (67, 13%). The lung was the most common primary for all ethnicities (n = 190, 40%). The second-most common primary site was the breast in African Americans and Caucasians and upper gastrointestinal (GI) tract in Asians. In 5 cases (1%), the primary tumor could not be determined. Conclusion: Cytology examination is a useful method to diagnose primary sites of PE. Pulmonary primary is the most common cause of effusion in all ethnicities. In African American and Caucasian patients, the breast was the second-most common site of MPE, while in Asian patients it was the upper GI tract.
This paper references
Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series.
F. Rodríguez-Panadero (1989)
10.4103/0970-9371.55223
Critical analysis of cell block versus smear examination in effusions
meenu thApAr (2009)
10.1002/cncr.23254
Utility of anti‐L523S antibody in the diagnosis of benign and malignant serous effusions
K. Hanley (2008)
10.5858/ARPA.2016-0091-SA
Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society.
S. Roy-Chowdhuri (2016)
10.1002/cncy.21518
The role of liquid‐based cytology and ancillary techniques in pleural and pericardic effusions: An institutional experience
E. Rossi (2015)
10.1513/AnnalsATS.201609-709OC
Molecular Profiling of Malignant Pleural Effusion in Metastatic Non‐Small‐Cell Lung Carcinoma. The Effect of Preanalytical Factors
Jamal Carter (2017)
10.1136/thx.2010.136978
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
C. Hooper (2010)
10.1002/1097-0142(19850815)56:4<905::AID-CNCR2820560435>3.0.CO;2-U
The malignant pleural effusion. A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients
W. W. Johnston (1985)
10.5858/ARPA.2016-0108-RA
Optimizing Workflows and Processing of Cytologic Samples for Comprehensive Analysis by Next-Generation Sequencing: Memorial Sloan Kettering Cancer Center Experience.
S. Tian (2016)
10.1097/00125480-200607000-00004
The Diagnosis of Malignancy in Effusion Cytology: A Pattern Recognition Approach
T. C. Pereira (2006)
10.1002/cncy.21452
A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: A retrospective analysis of 2540 cases
Lisa M. Rooper (2014)
10.1002/DC.2840030103
Cytologic detection of malignancy in pleural effusion: A review of 5,255 samples from 3,811 patients
C. Hsu (1987)
10.3322/caac.21395
Colorectal cancer statistics, 2017
R. Siegel (2017)
10.1053/j.gastro.2017.05.013
Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer.
D. Rex (2017)
10.5858/arpa.2017-0124-RA
Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group.
A. Husain (2018)
10.1097/PAI.0000000000000540
Paired Comparison of PD-L1 Expression on Cytologic and Histologic Specimens From Malignancies in the Lung Assessed With PD-L1 IHC 28-8pharmDx and PD-L1 IHC 22C3pharmDx
B. Skov (2017)
10.1097/JTO.0b013e31820517a3
Suitability of Thoracic Cytology for New Therapeutic Paradigms in Non-small Cell Lung Carcinoma: High Accuracy of Tumor Subtyping and Feasibility of EGFR and KRAS Molecular Testing
N. Rekhtman (2011)
10.1016/S0025-6196(12)60212-2
Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases.
U. Prakash (1985)
10.1159/000477148
Molecular Alterations in Patients with Pulmonary Adenocarcinoma Presenting with Malignant Pleural Effusion at the First Diagnosis
E. Rodriguez (2017)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar